Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
29.09%
↑ 153% above average
Average (22q)
-54.76%
Historical baseline
Range
High:63.33%
Low:-983.92%
Volatility
-1912.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 29.09% |
| Q2 2025 | -44.74% |
| Q1 2025 | -5.56% |
| Q4 2024 | 29.41% |
| Q3 2024 | -363.64% |
| Q2 2024 | 63.33% |
| Q1 2024 | -20.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 40.48% |
| Q2 2023 | 0.00% |
| Q1 2023 | -7.69% |
| Q4 2022 | -14.71% |
| Q3 2022 | 15.00% |
| Q2 2022 | -25.00% |
| Q1 2022 | 3.03% |
| Q4 2021 | -26.92% |
| Q3 2021 | 58.06% |
| Q2 2021 | -983.92% |
| Q1 2021 | 56.00% |
| Q4 2020 | -30.00% |
| Q3 2020 | 50.00% |
| Q2 2020 | -81.82% |
| Q1 2020 | 0.00% |